Medical University of Warsaw, Department of Paediatrics, Warsaw, Poland
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Szypowska, Agnieszka
NCT04019821: Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

Completed
4
72
Europe
Insulin Glulisine, Apidra, Insulin Aspart, NovoRapid, Insulin Lispro, Humalog, Liprolog
Medical University of Warsaw
Diabetes Mellitus, Type 1
01/23
04/23
NCT04772729: Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

Not yet recruiting
4
77
NA
Insulin faster aspart (Fiasp, Novo Nordisk), Insulin aspart (Novo Rapid, Novo Nordisk)
Medical University of Warsaw
Diabetes type1, Diabetes Mellitus, Type 1
03/23
03/24
PRIFEN, NCT05909800: Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.

Recruiting
2
102
Europe
Phenofibrate, Fenofibrate, Fenofibratum, SUB07576MIG, CAS no. 49562-28-9, Placebo, inactive drug, inactive medicine, inactive substance.
Medical University of Warsaw, Children's Memorial Health Institute, Poland
Diabetes Mellitus, Type 1
07/24
07/24
SINT1A, NCT04769037: Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity

Recruiting
N/A
1144
Europe
B. infantis, Placebo
Helmholtz Zentrum München, Technical University of Munich, Kinderkrankenhaus auf der Bult, University Hospital Carl Gustav Carus, Skane University Hospital, Universitaire Ziekenhuizen KU Leuven, Medical University of Warsaw, Cambridge Biomedical Campus, Cambridge, UK, Royal Victoria Infirmary, Newcastle upon Tyne, UK
Diabetes Mellitus, Type 1
10/27
10/27

Download Options